an innovative device for the treatment of HCM, was developed in-house by Hangzhou Nuocheng Medical Technology Co., Ltd., a wholly-owned subsidiary of Venus Medtech.
This product introduces a breakthrough therapy for HCM through the internationally pioneering echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) technique. It provides a safe, effective, precise and minimally invasive approach to treating HCM.


Copy product links
Long by picture save/share





